Transplant Co-Morbidity Superpanel
Gene: MT-RNR1
Multiple variations within the MT-RNR1 gene have been associated with the development of hearing loss in patients who receive aminoglycoside antibiotics. Aminoglycosides are a class of antibiotics that includes drugs such as streptomycin, kanamycin, gentamycin and tobramycin, among others.
https://www.pharmgkb.org/gene/PA31274
The 1555A>G variation in the MT-RNR1 gene is strongly associated with the development of bilateral, sensorineural, nonsyndromic hearing loss following aminoglycoside antibiotic use: across 40 studies in either family pedigrees or groups of patients with hearing loss, 100% of those with the MT-RNR1 1555G variant who received an aminoglycoside antibiotic developed hearing loss. (PMID:9164619)
Sources: Expert listCreated: 25 Aug 2023, 5:59 a.m.
Mode of inheritance
MITOCHONDRIAL
Phenotypes
Deafness, mitochondrial, modifier of MIM# 580000
Gene: mt-rnr1 has been classified as Green List (High Evidence).
Gene: mt-rnr1 has been classified as Green List (High Evidence).
gene: MT-RNR1 was added gene: MT-RNR1 was added to Transplant Co-Morbidity Superpanel. Sources: Expert list Mode of inheritance for gene gene: MT-RNR1 was set to MITOCHONDRIAL Phenotypes for gene: MT-RNR1 were set to Deafness, mitochondrial, modifier of MIM# 580000 Review for gene: MT-RNR1 was set to GREEN